| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly is showcasing strong momentum in product development, particularly in innovative treatments for obesity and diabetes, which are expected to drive future earnings. Positive clinical trial results, especially for conditions such as alopecia and atopic dermatitis, further accentuate the company's commitment to advancing healthcare solutions. The successful launches of products like Mounjaro and Zepbound signal significant growth potential within the pharmaceutical market. Additionally, investments in gene therapy underscore an alignment with emerging biotechnology trends aimed at addressing critical health issues. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-10-26. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.2) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-26 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-10-25 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-10-24 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | 6 | |||||||
| 2025-10-23 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| 2025-10-22 | 0%(0%) | 0 | 0% | 0.2 | 2.4 | -1 | |||||||
| 2025-10-21 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2025-10-20 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-10-19 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-10-18 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-17 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | -6 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-26 17:01:19 The selection of stocks to watch indicates the reliance on market analysis and expert opinions in investment decisions. |
| 2025-10-26 17:01:19 The acquisition of Adverum Biotechnologies underlines strategic investment moves within the industry. |
| 2025-10-26 17:01:19 The emphasis on Eli Lilly's product launches, particularly Zepbound and Mounjaro, highlights ongoing innovation in pharmaceuticals. |
| 2025-10-26 17:01:19 The article discusses trends within the pharmaceutical industry, noting key companies that are leading the market. |
| 2025-10-26 17:01:19 Eli Lilly's stock price has shown significant improvement and is a focal point in the analysis of pharmaceutical stocks. |